Biosimilars Conference

November 18 - 19, 2009 • Berlin, Germany

With 20 speakers confirmed, this year’s Biosimilars conference is set to be jam-packed. Don’t miss the chance to:

Explore the latest developments in the US. What are the upcoming futures and challenges?
Revisit the EU Market. Learn what the growth drivers and restraints have been and what products to look out for
Evaluate the market from an innovator, biosimilar and dual perspective with presentations from Roche Pharma Research, Intas Pharmaceuticals and Merck Bioventures
Discover recent developments and comparability approaches to biosimilar mAbs. Learn the challenges and regulatory requirements that must be considered
Update your knowledge on advancements in biosimilar comparability, immunogenicity, formulation and pharmacokinetics
Analyse regulatory expectations on a Global basis and discover further information on development costs and the potential future impact in emerging markets
Ascertain what the payer’s perception is of the biosimilar market and the pricing and access environment for biosimilars
Familiarise yourself with patent law strategies and the ones to watch out for